Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04921462
Other study ID # RC20/509
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 29, 2020
Est. completion date May 4, 2021

Study information

Verified date June 2021
Source King Abdulaziz Medical City
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aimed to evaluate the effectiveness of silastic septal splint in reducing the rates of complications, decreasing the post-operative pain, and improving satisfaction in comparison to quilting suturing technique. Methods: A single center randomized controlled trial, including adult above the age of 18. A total of 50 participants who underwent septoplasty were enrolled and randomly assigned into two groups, Silastic group (n=25), and quilting group (n=25). Nasal obstruction severity was assessed by using an Arabic validated version of NOSE score, preoperatively then 3 days, one week and one month postoperatively. Post-operative complications were assessed at outpatient clinic 1 week and 1 month postoperatively. Pain was assessed by a 10-point numerical scales via phone call on the 3rd day postoperative.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date May 4, 2021
Est. primary completion date March 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult (= 18 years) healthy individuals of both genders with deviated nasal septum and no other concomitant procedures. Exclusion Criteria: - 1. Concomitant procedure other than septoplasty. 2. Previous history of septal or nasal surgery. 3. Presence of nasal polyps, chronic sinusitis or other regional pathology. 4. Bleeding disorders or anticoagulation therapy.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Septoplasty surgery
septoplasty procedures were performed by a single surgeon using the same technique among all patients. The procedures were conducted under general anesthesia according to the standard preoperative care used in our institution.

Locations

Country Name City State
Saudi Arabia King Abdulaziz Medical City Riyadh

Sponsors (1)

Lead Sponsor Collaborator
King Abdulaziz Medical City

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in NOSE score 1 month postoperatively NOSE change = preoperative NOSE - 1 month postoperative NOSE 1 month postoperatively
Secondary Validated NOSE score NOSE score preoperatively, 3 days, 1 week and 1 month postoperatively
Secondary complications Bleeding, Bad smell, Synechia, Crustation and Perforation 1 month
Secondary postoperative pain using numerical Pain scale (0 to 10) at 3 days postoperative
Secondary general satisfaction questionnaire at 1 month postoperative
See also
  Status Clinical Trial Phase
Completed NCT04392583 - Safety and Performance of ENTACT Septal Staple System for Septoplasty
Recruiting NCT04020367 - Validation of a Process for the Manufacture of Stem Cells Isolated From the Nasal Cavity for Innovative Cell Therapy of Traumatized Peripheral Nerves N/A